About 100 reports

  • STAGE DEFINITIONS FOR COLORECTAL CANCER
  • TREATMENT DURATION IN COLORECTAL CANCER

PharmaPoint: Colorectal Cancer - Global Drug Forecast and Market Analysis to 2025 Summary Colorectal Cancer (CRC) Market, considering the sales of both branded treatments and generic chemotherapy, is expected to experience a moderate growth between 2015 and 2025. The main drivers of growth will be the expected increased...

  • Colorectal Cancer
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Roche Group
  • Taiho Pharmaceutical Co., Ltd.
  • Aging Population to Increase Disease Prevalence
  • CRC THERAPEUTICS MARKET, GLOBAL, ALL PIPELINE PRODUCTS, PRE-REGISTRATION, 2018

Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2024 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market Summary Many countries are facing the challenge of an aging population, and there will be an increased number of people aged 50 and over – a high-risk...

  • Cancer
  • Colorectal Cancer
  • World
  • Market Size
  • Merck & Co., Inc.
  • 3.1 BIBLIOGRAPHY
  • MM, Five-Year Diagnosed Prevalent Cases of CRC (N), Both Sexes, Ages ≥18 Years,

EpiCast Report: Colorectal Cancer - Epidemiology Forecast to 2025 Summary Colorectal cancer (CRC) is a cancer that starts in the colon or the rectum (ACS, 2016). CRC is one of the most common types of cancers diagnosed; it is the third most common cancer among men and the second most common in women, worldwide (Ferlay...

  • Colorectal Cancer
  • China
  • United States
  • Forecast
  • Cancer Epidemiology Group
  • 1.1 Colorectal Cancer
  • GLOBAL COLORECTAL CANCER INCIDENCES FORECAST (2017-2022)

Colorectal cancer, also known as bowel cancer and colon cancer, is the development of the cancer in the colon or rectum. A cancer is the abnormal growth of the cells that have the ability to invade or spread to the other parts of the body. Colorectal cancer begins when the healthy cells in the lining of the colon or...

  • Colorectal Cancer
  • United States
  • Forecast
  • Epigenomics AG
  • Exact Sciences Corp.

Global Colorectal Cancer Epidemiology and Patient Flow Analysis - 2017 ##.

  • Colorectal Cancer
  • France
  • United States
  • World
  • Forecast
  • Colorectal Cancer Development Pipeline, by Phase
  • Top Targets for Drug Development Against Colorectal Cancer

Colorectal Cancer: Competitive Landscape to 2026 Summary Colorectal cancer (CRC) is a cancer that originates in either the colon or the rectum.CRC is the fourth leading cause of mortality among cancer patients in the world, and is the third most diagnosed cancer globally. Most cases of CRC...

  • Colorectal Cancer
  • China
  • United States
  • Array BioPharma Inc.
  • Eli Lilly & Co.

Colorectal Cancer: Update Bulletin ### This edition presents the views and insights from three world leading key opinion leaders (KOLs) from North America and Europe on a variety of recent events in the colorectal cancer (CRC) market, including; Symphogen

  • Colorectal Cancer
  • Monoclonal Antibody
  • Therapy
  • Europe

Colorectal Cancer: Update Bulletin ### [March 2018] Gain new key opinion leader (KOL) insights on the latest events happening in the CRC treatment landscape Topics covered include expert opinions on; the potential of MabVax Therapeutics’ human antibody-based radioimmunotherapy produ

  • Cancer Immunotherapy
  • Colorectal Cancer
  • Monoclonal Antibody
  • Oncology
  • Therapy

Products in the pipeline are striving to meet some of the unmet needs of the colorectal cancer (CRC) market.

  • Cancer
  • Colorectal Cancer
  • Pathology
  • United States
  • Forecast
  • Global Colorectal Cancer Drugs Market
  • Global Colorectal Cancer Drugs Market

About Colorectal Cancer Colorectal cancer refers to malignancies that originate in the rectum or the colon. It is also known as bowel cancer. Formation of adenocarcinomas is the most common feature of colorectal cancer. The cancer starts as a polyp in the inner wall of the colon or rectum. These polyps can be benign or malignant. Colorectal...

  • Colorectal Cancer
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche Ltd.
  • Merck Serono S.A.
  • 5.2 References
  • Introduction

Colorectal Cancer - Heat Map and Analysis Summary Colorectal cancer (CRC), otherwise known as bowel cancer, is a malignancy originating in the colon (the large intestine) or rectum, both of which are located towards the end of the human gastrointestinal tract. It begins as a benign tumor, which is almost always...

  • Cancer
  • Colorectal Cancer
  • Therapy
  • United States
  • Roche Group

Colorectal Cancer Phase ## Clinical Trials, 2016 ##.

  • Colorectal Cancer
  • France
  • United States
  • Market Shares
  • Market Size

Colorectal cancer

4546 5000 3864
  • Colorectal cancer Disease Coverage | Pipeline: Colorectal Cancer
  • Colorectal cancer Disease Coverage | Pipeline: Colorectal Cancer

Pipeline candidates for the colorectal cancer market will pursue novel mechanisms of action to distinguish themselves in an increasingly crowded market. This report addresses the following questions: - How are new therapies differentiating themselves in the increasingly crowded and price-sensitive CRC market? - How...

  • Colorectal Cancer
  • European Union
  • Japan
  • North America
  • United States

Colorectal Cancer (CRC) -Epidemiology Forecast to 2027 ##.

  • Colorectal Cancer
  • France
  • Germany
  • Italy
  • Spain

Colorectal Cancer Forecast and Market Analysis to 2036 FORECAST: COLORECTAL CANCER IN THE US, JAPAN, AND ##EU (Published on ## December 2017) EXECUTIVE SUMMARY RECENT FORECAST UPDATES MARKET DYNAMICS FORECAST AND FUTURE TRENDS MARKET DEFINITION AND METHODOLOGY PRIM

  • Colorectal Cancer
  • European Union
  • Japan
  • United States
  • Demand

Europe Colorectal Cancer Epidemiology and Patient Flow Analysis - 2017 ##.

  • Colorectal Cancer
  • Europe
  • France
  • Germany
  • Forecast
  • TREATMENT OF COLORECTAL CANCER PATIENTS
  • Duke's Staging Of Colorectal Cancer

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Colorectal Cancer in 18 Major Markets Colorectal Cancer (CRC) affects the colon and rectum, which are a part of the large intestine. Colorectal cancer occurs when tumours, identified as polyps, develop in the lining of the large intestine. Some of these polyps can become...

  • Colorectal Cancer
  • Italy
  • North America
  • South America
  • Southern Europe

Colorectal Cancer (CRC) - Market Insight, Epidemiology and Market Forecast - 2027 ##.

  • Cancer
  • Colorectal Cancer
  • Pathology
  • United States
  • Market Shares
  • Local colorectal cancer symptoms
  • Systemic colorectal cancer symptoms

About colorectal cancer Colorectal cancer refers to malignancies that originate in the rectum or the colon. It is also known as bowel cancer. Formation of adenocarcinomas is the most common feature of colorectal cancer. The cancer starts as a polyp in the inner wall of the colon or rectum. These polyps can be benign or malignant. Some of...

  • Colorectal Cancer
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • Sanofi S.A.

Colorectal Cancer Phase ## Clinical Trials, 2016 ##.

  • Colorectal Cancer
  • France
  • Germany
  • Market Shares
  • Market Size

Colorectal Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Colorectal Cancer
  • United States
  • Market Shares
  • Market Size

Colorectal Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Colorectal Cancer
  • Japan
  • Market Shares
  • Market Size

Colorectal Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Colorectal Cancer
  • United Kingdom
  • Market Shares
  • Market Size

Colorectal Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Colorectal Cancer
  • Germany
  • Market Shares
  • Market Size

Colorectal Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Colorectal Cancer
  • Italy
  • Market Shares
  • Market Size

Colorectal Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Colorectal Cancer
  • France
  • Market Shares
  • Market Size

Colorectal Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Colorectal Cancer
  • Spain
  • Market Shares
  • Market Size

COLORECTAL CANCER DRUGS INDUSTRY AND MARKET: THERAPIES, R& D AND FORECASTS 2015-2025 Table of Contents ##.

  • Cancer
  • Colorectal Cancer
  • Pathology
  • World
  • Market Size
  • COLORECTAL CANCER BIOSIMILAR LANDSCAPE
  • HER2+ Breast Cancer

Biosimilars in Oncology Summary Recent trends in drug development have seen the price of new medicines continually increase, and there is a need for cheaper medicines to achieve global sustainable healthcare.Biologic drugs are some of the most expensive medicines to develop, as they are large complex...

  • Colorectal Cancer
  • Biocon Limited
  • Mylan Inc.
  • Pfizer Inc.
  • Sandoz Inc.
  • Growing incidence of colorectal cancer
  • Colorectal cancer mortality per 100,000 individuals in European countries 2003 and

About Fecal Occult Testing Fecal Occult Testing is a laboratory test used to check the stool sample of people. It is used in screening for colon cancer and for evaluating the probable causes of unexplained anaemia. Technavio’s analysts forecast the Global Fecal Occult Testing Market to grow at a CAGR of 4.61%...

  • Colorectal Cancer
  • Forecast
  • Market Size
  • Danaher Corporation
  • Epigenomics AG